Insights

Small pharma niche Berthoud Drug is a small-scale book and periodical publisher with a lean team (2-10 employees) and revenue under $1M, indicating a potential low-volume, highly specialized customer profile that may value cost-effective, lightweight sales engagements and scalable eCommerce or content distribution solutions.

Digital platform The company uses Wix and Wix eCommerce, Google Cloud, and Modernizr, suggesting they rely on accessible, web-based publishing platforms. Sales opportunities exist in lightweight CMS/hosting enhancements, SEO improvements, analytics, and security tooling compatible with their stack.

Tech stack fit Adoption of Mixpanel and Snowplow indicates a data-driven mindset around user behavior analytics. There is opportunity to offer advanced analytics, event-tracking implementations, or data visualizations to optimize reader engagement and monetization strategies.

Growth potential With revenue under $1M and market peers in the pharmacy and retail space, Berthoud Drug sits in a potential growth segment where cross-channel commerce, digital marketing services, and content monetization partnerships could unlock incremental revenue without requiring a large enterprise-level contract.

Competitive landscape Compared to large pharmacy chains, Berthoud Drug is small and independent. Position sales pitches around personalized service, flexible licensing, and scalable publishing technology that supports niche content delivery, seasonal promotions, and localized distribution efficiency.

Similar companies to Berthoud Drug

Berthoud Drug Tech Stack

Berthoud Drug uses 8 technology products and services including Mixpanel, Snowplow, Wix, and more. Explore Berthoud Drug's tech stack below.

Berthoud Drug's Email Address Formats

Berthoud Drug uses at least 0 email formats:
Berthoud Drug Email FormatsExamplePercentage

Frequently Asked Questions

What is Berthoud Drug's official website and social media links?

Minus sign iconPlus sign icon
Berthoud Drug's official website is berthouddrug.com and has social profiles on LinkedIn.

How much revenue does Berthoud Drug generate?

Minus sign iconPlus sign icon
As of September 2026, Berthoud Drug's annual revenue is estimated to be <$1M.

What is Berthoud Drug's SIC code and NAICS code?

Minus sign iconPlus sign icon
Berthoud Drug's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries and NAICS code is 511 - Publishing Industries (except Internet).

How many employees does Berthoud Drug have currently?

Minus sign iconPlus sign icon
As of September 2026, Berthoud Drug has approximately 2 employees across 1 continents, including North America. Key team members include : K. F. Explore Berthoud Drug's employee directory with LeadIQ.

What industry does Berthoud Drug belong to?

Minus sign iconPlus sign icon
Berthoud Drug operates in the Book and Periodical Publishing industry.

What technology does Berthoud Drug use?

Minus sign iconPlus sign icon
Berthoud Drug's tech stack includes Mixpanel, Snowplow, Wix, Wix eCommerce, Microsoft 365, Google Cloud, Sentry and Modernizr.
Berthoud Drug logo

Berthoud Drug

Book and Periodical PublishingColorado, United States2-10 Employees

Berthoud Drug operates in the book and periodical publishing industry and is based in Berthoud, Colorado. It appears to be a small enterprise with a modest workforce. The company maintains a website at berthouddrug.com.

Information about its customers or target markets is not provided in the available data. The description references LinkedIn as a recruitment channel, indicating an online presence used for hiring alongside its website.

Section iconCompany Overview

SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
511 - Publishing Industries (except Internet)
Employees
2-10

Section iconFunding & Financials

  • <$1M

    Berthoud Drug's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.